In NSCLC, we characterized CD8-ZNF683-T1 (LEF+/TBX21-) and CD8-ZNF683-T2 (LEF+/TBX21+) from CD8-ZNF683 (Figure 6a). This evidence concerns the gene CD8A and non-small cell lung carcinoma.